ALDA Pharmaceuticals Corp. - Financial Analysis Review
Summary
ALDA Pharmaceuticals Corp. (ALDA) is focused on the production and marketing of innovative infection control products. The Company’s main business activity is the development, production and marketing of products, based on T36 technology. The company was founded in 1996 by Dr. Allan Shapiro and is headquartered in NewWestminster, British Columbia.
Global Markets Direct’s "ALDA Pharmaceuticals Corp. - Financial Analysis Review” is an in-depth business and financial analysis of ALDA Pharmaceuticals Corp.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.
And More inside the report…
Recent Developments
Aug 07, 2009: ALDA Presents T36 Antiseptic Hand Sanitizer
Jul 14, 2009: ALDA Receives US Patent For T36
Scope
- Provides key company information for business intelligence needs
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with insight into the companies’ financial performance.
Report Highlights
[Cerrar las informaciones del articulo de mercado]
